Trade Summary

2 days ago, ROTHBLATT MARTINE A, serving as Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 8,000 shares at $572.38 per share, for a total transaction value of $4,579,017.69. Following this transaction, ROTHBLATT MARTINE A now holds 40,513 shares of UTHR.

This sale represents a 16.49% decrease in ROTHBLATT MARTINE A's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, May 26, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 27, 2026 at 4:30 PM ET, 1 day after the trade was made.

UNITED THERAPEUTICS Corp operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.